At close: January 8 at 4:00:00 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 5 | 3 | 4 | 5 |
| Avg. Estimate | 2.38M | 3M | 5.32M | 13.82M |
| Low Estimate | -- | 2.8M | 3.09M | -- |
| High Estimate | 3.1M | 3.2M | 6.2M | 32.2M |
| Year Ago Sales | -- | -- | -- | 5.32M |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 159.77% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| GOVXW | -- | -- | -- | -- |
| S&P 500 | 8.70% | 11.55% | 14.03% | 13.42% |
Related Tickers
CDTTW Conduit Pharmaceuticals Inc.
0.0110
-1.79%
IMTXW Immatics N.V.
0.1475
-15.71%
WSNAF Wesana Health Holdings Inc.
0.0027
0.00%
SRZNW Surrozen, Inc.
0.0500
0.00%
DRMAW Dermata Therapeutics, Inc.
0.0112
-24.32%
WXIBF WuXi Biologics (Cayman) Inc.
2.1700
0.00%
TYPTF
0.0280
0.00%
KTTAW Pasithea Therapeutics Corp.
0.0251
0.00%
KRBP Kiromic BioPharma, Inc.
0.9250
0.00%
SCPS Scopus BioPharma Inc.
0.0003
0.00%